EPITOPE  EPTO SETS THREE FOR ONE STOCK SPLIT BEAVERTON ORE MARCH 2 EPITOPE INC SAID ITS BOARD OF DIRECTORS HAS AUTHORIZED A THREE FOR ONE COMMON STOCK SPLIT FOR WHICH SHAREHOLDER APPROVAL IS EXPECTED IN THE NEXT TWO WEEKS THE COMPANY ANNOUNCED A TWO FOR ONE SPLIT LAST WEEK BUT SAID THE BOARD RECONVENED AND AGREED TO CHANGE IT TO A THREE FOR ONE SPLIT EPITOPE IS INVOLVED IN THE PRODUCTION OF MONOCLONAL ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE IN AIDS AND OTHER IMMUNOLOGICAL DISEASES   